CELL MOL LIFE SCI 润色咨询

CELLULAR AND MOLECULAR LIFE SCIENCES

出版年份:1997 年文章数:4705 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:1.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-07-04 野生鄢医师 来自瑞典

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:免疫
    经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。

    9

    展开9条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-03-06 ms4000002086735612 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:免疫;转录调控;表观
    经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了
    20221123 with editor
    1127 Under Review
    1128 Under Review
    1201 Under Review
    1207 Under Review
    1222 Required Reviews Completed
    1226 Major Revision
    20230206 Revision Submittedd to Journal
    20230207 With Editor
    20230208 Under Review
    20230221 Required Reviews Completed
    20230303 Accept

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-07-27 ms4000001963140241 来自四川省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:代谢
    经验分享:23.5月初投稿
    23.5.30拒稿有审稿意见
    23.7.4根据意见返修重投
    23.7.8格式问题返回当天投回
    23.7.9分配编辑
    23.7.11外审
    23.7.26接收

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-09-27 ms5000000478145561 来自湖北省

    偏重的研究方向:认知功能
    经验分享:9.23重新提交,到现在还是with editor,等。。。

    13

    展开13条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2022-11-09 ms3000001732307962

    偏重的研究方向:分子生物
    经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-05-24 ms8000000172957012 来自内蒙古

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:Article;发育
    经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-08-12 ms3000002138781208 来自上海

    求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2023-08-10 541277062 来自四川省

    哪位大神有这个endnote格式?

    3

    展开3条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2022-11-12 小甜甜66

    中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2146308, encodeId=760d21463086f, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫<br>经验分享:二月底投稿,三个审稿人给了超级详细的意见,但是编辑只给了一个月时间返修,尽可能补了体外实验,然后非常详细地回答了审稿人的问题,最终六月一号接收。总时间3个多月,效率很高的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/01/15008218b0b59d0dd94ef1d4392402e4.jpg, createdBy=686d5219328, createdName=野生鄢医师, createdTime=Tue Jul 04 18:49:36 CST 2023, time=2023-07-04, status=1, ipAttribution=瑞典), GetPortalCommentsPageByObjectIdResponse(id=2117900, encodeId=808d211e90005, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:免疫;转录调控;表观<br>经验分享:感觉编辑处理的很快,Under Review这么快我都有点不相信,投稿时间过程分享给大家。3个审稿人问的问题很仔细,有些结论我写的有些唐突了,审稿人还帮我提出了一些结论分享给我,学习到了很多。其中一个审稿人必须让我补一个实验,有点强人所难,还是没有补,好说歹说给他分析了一些公共数据,还好审稿人心软,感谢了<br>20221123 with editor<br>1127 Under Review<br>1128 Under Review<br>1201 Under Review<br>1207 Under Review<br>1222 Required Reviews Completed<br>1226 Major Revision<br>20230206 Revision Submittedd to Journal<br>20230207 With Editor<br>20230208 Under Review<br>20230221 Required Reviews Completed<br>20230303 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=550f8099523, createdName=ms4000002086735612, createdTime=Mon Mar 06 11:04:26 CST 2023, time=2023-03-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150039, encodeId=d4e92150039a4, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:代谢<br>经验分享:23.5月初投稿<br>23.5.30拒稿有审稿意见<br>23.7.4根据意见返修重投<br>23.7.8格式问题返回当天投回<br>23.7.9分配编辑<br>23.7.11外审<br>23.7.26接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4df08470827, createdName=ms4000001963140241, createdTime=Thu Jul 27 01:08:09 CST 2023, time=2023-07-27, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2160084, encodeId=c29f2160084a5, content=偏重的研究方向:认知功能<br>经验分享:9.23重新提交,到现在还是with editor,等。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e3681f373ed24df6bafb345b9d0c6b08-gpXVmJ4OaNdk.jpg, createdBy=6c728443660, createdName=ms5000000478145561, createdTime=Wed Sep 27 19:54:21 CST 2023, time=2023-09-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2099349, encodeId=f8cf209934993, content=偏重的研究方向:分子生物<br>经验分享:with editor 9天了 还没有消息,大家的状态是多久啊 这个杂志不是说编辑一周么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1de26577218, createdName=ms3000001732307962, createdTime=Wed Nov 09 10:39:11 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138744, encodeId=a3a82138e4457, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:Article;发育<br>经验分享:我5.15投稿,5.16 状态变为With editor, 5.23的状态改变,但是就是日期变了一下,还是在With editor那里 有哪位大神知道是什么情况嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d77c6565435, createdName=ms8000000172957012, createdTime=Wed May 24 08:42:15 CST 2023, time=2023-05-24, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2152421, encodeId=26bc2152421a4, content=求解是不是用了新系统提交的都算OA了,版面费2.7W啊。为啥新系统效率变这么慢,一周了编辑看都不看,等着毕业的娃伤不起啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2adf8661247, createdName=ms3000002138781208, createdTime=Sat Aug 12 13:14:20 CST 2023, time=2023-08-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2152104, encodeId=7e442152104e2, content=哪位大神有这个endnote格式?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ef4b3076664, createdName=541277062, createdTime=Thu Aug 10 14:20:48 CST 2023, time=2023-08-10, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2100124, encodeId=086e210012407, content=中国人的文章非常少。。。感觉这个杂志太难了,投了三次都没送外审,果断放弃,应该是1区水平。很低调的欧洲生物杂志。上面有好几个诺贝尔奖的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210205/05b5037b86db4c98a206f2987b4d2b0a/90631ca66a734b018e412f1891933dce.jpg, createdBy=6a6f1855273, createdName=小甜甜66, createdTime=Sat Nov 12 17:59:01 CST 2022, time=2022-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562168, encodeId=045a56216834, content=请问您之后等了多久才外审呢?<span class="quote">ginobily1 2017-12-07 发表::<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span><span class="quote">ginobily1 2017-12-07 18:54:00 发表:<br>我投过去快3周了,还是With ethor,有大神知道什么情况吗?</span>, beContent=ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4e2a2032555, createdName=yu0608, createdTime=Fri Oct 19 00:00:00 CST 2018, time=2018-10-19, status=1, ipAttribution=)]
    2018-10-19 yu0608

    请问您之后等了多久才外审呢?ginobily1 2017-12-07 发表::
    我投过去快3周了,还是With ethor,有大神知道什么情况吗?
    ginobily1 2017-12-07 18:54:00 发表:
    我投过去快3周了,还是With ethor,有大神知道什么情况吗?

    ginobily1 2017-12-07 发表:: 我投过去快3周了,还是With ethor,有大神知道什么情况吗?

    2

    展开2条回复
共240条页码: 2/24页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分